NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/12/2026
Back to search
Official data from USPTO
UNITED THERAPEUTICS CORPORATION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
UNITED THERAPEUTICS CORPORATION
ST13
US500000086723910Class
5
Filing
86723910
Registration
4967867
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
07/07/2026
Trademark type
Word
Nice classes
5
Filing date
08/13/2015
Registration date
05/31/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/12/2026
Last transaction
07/07/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
12/08/1997
First use in commerce
12/08/1997
Drawing code
4
Owner type
03
Owner location
Silver Spring, MD, US
Examiner
WOOD, CAROLINE
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
U. C. (pessoa física)
Representatives
Norm J. Rich Foley & Lardner Llp
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of heart diseaselung diseasevascular diseasecancer; tumor suppressing agents
Publications
History of USPTO decisions and trademark events.
27 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/12/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/12/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/10/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
04/06/2026
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/01/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/05/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/05/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/05/2022
E815
TEAS SECTION 8 & 15 RECEIVED
05/05/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/31/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
05/31/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/15/2016
PUBO
PUBLISHED FOR OPPOSITION
03/15/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/24/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/01/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
02/01/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/01/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
02/01/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/01/2016
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
11/23/2015
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
11/23/2015
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
11/23/2015
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
11/23/2015
DOCK
ASSIGNED TO EXAMINER
11/18/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/18/2015
NWAP
NEW APPLICATION ENTERED
08/17/2015
Continuous trademark protection
Get notified about every new filing that threatens UNITED THERAPEUTICS CORPORATION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.